Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults
Authors:
Open Access
- 16 February 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (2) , e2146798
Abstract
As of December 15, 2021, Canada had reported more than 1.8 million cases of SARS-CoV-2 infection and approximately 30 000 deaths associated with COVID-19. Slightly fewer than 60% of cases and more than 80% of deaths occurred during the combined first (April to July 2020) and second (October 2020 to March 2021) viral waves, when the original SARS-CoV-2 was the predominant strain in circulation.1 Before the onset of the viral wave caused by the Omicron variant, which began on December 15, 2021, reported case rates in Canada (Figure 1) had been approximately one-third of those in the US and one-half of those in the United Kingdom.2 At the population level, the incidence of infection during each wave, the factors associated with infection, the levels and factors associated with asymptomatic infection, and the durability of antibody responses against infection remain uncertain.Keywords
This publication has 28 references indexed in Scilit:
- Humoral Immune Response to SARS-CoV-2 in IcelandNew England Journal of Medicine, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020
- Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020medRxiv, 2020
- Characterizing early Canadian federal, provincial, territorial and municipal nonpharmaceutical interventions in response to COVID-19: a descriptive analysisCMAJ Open, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- Mortality from COVID-19 in 12 countries and 6 states of the United StatesmedRxiv, 2020
- Blood pressure and hypertension2019
- Biobanks in Developing Countries: Needs and FeasibilityScience, 2007
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationAnnals of Internal Medicine, 2007
- World Health Organization quality assessment programme on HIV testingAIDS, 1990